Search

Displaying results 6751 - 6760 of 8696 in total
  1. Drug

    Dexamethasone palmitate

    go.drugbank.com/drugs/DB19168
    Investigational

    Dexamethasone palmitate is under investigation in clinical trial NCT05693467 (Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery).

  2. Drug

    Ridinilazole

    go.drugbank.com/drugs/DB15308
    Investigational

    Ridinilazole is under investigation in clinical trial NCT02092935 (A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)).

  3. Drug

    Balamapimod

    go.drugbank.com/drugs/DB20250
    Experimental

    The usage of the INN stem '-mapimod' in the name indicates that Balamapimod is a mitogen-activated protein (MAP) kinase inhibitor. Balamapimod has a monoisotopic molecular weight of 573.21 Da.

  4. Drug

    Sembragiline

    go.drugbank.com/drugs/DB20857
    Experimental

    The usage of the INN stem '-giline' in the name indicates that Sembragiline is a monoamine oxydase (MAO)-inhibitor type B. Sembragiline has a monoisotopic molecular weight of 342.14 Da.

  5. Drug

    ICG-136

    go.drugbank.com/drugs/DB17343
    Experimental

    ICG-136 is a compound chimeric antigen receptor (cCAR) T-cell therapy developed by iCell Gene Therapeutics. It was investigated for the treatment of acute myeloid leukemia.

  6. Drug

    Mozafancogene autotemcel

    go.drugbank.com/drugs/DB17723
    Investigational

    RP-L102 is a lentiviral vector carrying the Fanconi Anemia-A (FANCA) gene currently being developed by Rocket Pharmaceuticals for the treatment of Fanconi anemia type A

  7. Drug

    Surovatamig

    go.drugbank.com/drugs/DB19420
    Investigational

    TNB-486 is under investigation in clinical trial NCT06564038 (A Study of AZD0486 Monotherapy or in Combination With Other Anti-cancer Agents for Mature B-cell Malignancies).

  8. Drug

    Etaracizumab

    go.drugbank.com/drugs/DB12213
    Investigational

    Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.

  9. Drug

    Peldesine

    go.drugbank.com/drugs/DB02568
    Investigational

    It has undergone phase I trials for the treatment of Human Immunodeficiency Virus (HIV) infections.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
  10. Drug

    Telapristone acetate

    go.drugbank.com/drugs/DB05253
    Investigational

    Telapristone acetate, an orally-available, selective progesterone receptor modulator, is in development to alleviate symptoms associated with both uterine fibroids and endometriosis.